Industry News
Australian Export Council conducts in-depth survey on exports
To better understand the export behaviour of Australian companies and help shape Australia's future trade agenda, the Australian Export Council is conducting Australia's International Business Survey. [ + ]
Imugene steps in to buy Biolife Science
Imugene (ASX:IMU) has agreed to buy Biolife Science, the cancer immunotherapy company that called off a backdoor ASX listing and capital raising earlier this year. [ + ]
Immuron granted US Travelan patent
Immuron (ASX:IMC) has secured a US patent covering products developed with its colostrum platform technology, as it progresses with talks to bring Travelan to the US. [ + ]
Last chance to register for the biotech industry event of the year: AusBiotech 2013
Brisbane will welcome more than 1000 of the brightest brains in biotechnology and innovation next week for the official launch of the AusBiotech 2013 national conference; a premier event on the Australian and Asia-Pacific calendar. [ + ]
Melbourne hosts biotech investment conference
Life sciences investment event AusBiotech Invest Conference will take place from 28-29 October at the Melbourne Convention and Exhibition Centre. [ + ]
Heisenberg's error-disturbance relation proved correct
One of the basic concepts in quantum mechanics is that it is impossible to observe physical objects without affecting them in a significant way; there can be no measurement without disturbance. In 1927, theoretical physicist Werner Heisenberg claimed that this fact could be expressed as an uncertainty relation, describing a reciprocal relation between the accuracy in position and the disturbance in momentum. [ + ]
New leaders at Trajan
Trajan has made a number of key appointments to its leadership team. [ + ]
Grants announced for a healthier WA
The first Telethon-Perth Children's Hospital Research Fund has provided the impetus for 17 projects. [ + ]
Molecular manoeuvring with gesture and voice
Visualising the structures of complex molecules is now a whole lot easier with a new toolkit. [ + ]
Biggest donation for UWA
Wealth as a gift for the University of Western Australia. [ + ]
Coridon hits dosing milestone in herpes trial
The 20 subjects enrolled in a trial of the HSV-2 vaccine under development at Allied Healthcare's (ASX:AHZ) Coridon have all received two out of three planned doses. [ + ]
Genea Biocells claims MD breakthrough
Genea Biocells has produced human skeletal muscle from stem cells, in a breakthrough technique with potential applications in the treatment of muscular dystrophies. [ + ]
Melanoma Genome Project on track
The Melanoma Genome Project is well underway with sequencing data submitted to the International Cancer Genome Consortium repository and expectations this will be publicly available early next year. [ + ]
Technical guidelines for therapeutic services open for comment
The Department of Health and Ageing has released draft technical guidelines for therapeutic services, open for consultation until 23 November 2013. [ + ]
iSonea teams with uHealth for AirSonea push
Sydney-based uHealth will work with iSonea (ASX:ISN) to pursue more sales opportunities for the latter's asthma symptom monitoring device, AirSonea. [ + ]